GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -198 | -3,495 | -3,269 | -2,904 | -1,148 |
| Depreciation Amortization | 70 | 412 | 290 | 234 | 110 |
| Accounts receivable | -27 | 353 | 344 | 148 | 123 |
| Accounts payable and accrued liabilities | -42 | -39 | -6 | 71 | -111 |
| Other Working Capital | -266 | 644 | 364 | 213 | 33 |
| Other Operating Activity | 7 | 700 | 723 | 723 | -12 |
| Operating Cash Flow | $-456 | $-1,425 | $-1,554 | $-1,515 | $-1,005 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -11 | -10 | -10 | -4 |
| Sale Of Investment | N/A | 19 | N/A | N/A | N/A |
| Other Investing Activity | -29 | -164 | -55 | -57 | -2 |
| Investing Cash Flow | $-29 | $-156 | $-65 | $-67 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -47 | -212 | N/A | -15 | -7 |
| Other Financing Activity | 1,500 | 0 | -182 | 0 | 0 |
| Financing Cash Flow | $1,453 | $-212 | $-182 | $-15 | $-7 |
| Exchange Rate Effect | N/A | -45 | N/A | N/A | N/A |
| Beginning Cash Position | 221 | 2,059 | 2,059 | 2,059 | 2,059 |
| End Cash Position | 1,189 | 221 | 258 | 462 | 1,041 |
| Net Cash Flow | $968 | $-1,838 | $-1,801 | $-1,597 | $-1,018 |
| Free Cash Flow | |||||
| Operating Cash Flow | -456 | -1,425 | -1,554 | -1,515 | -1,005 |
| Capital Expenditure | N/A | -11 | -10 | -10 | -4 |
| Free Cash Flow | -456 | -1,436 | -1,564 | -1,525 | -1,009 |